On 31 December 2015, the FDA published draft guidance for Industry and FDA Administration. The FDA accepted comments from industry through 29 March 2016. Based on the comments, it is likely that the guidance will change. However, it is clear that the FDA is actively taking steps in asserting its mandate to protect the public health. In this webinar we will discuss how to transform your quality management system from compliance-based to quality-based.
The FDA is asserting its mandate to protect the public health with a proposal for notifying the public about "emerging signals". This proposal, along with other changes, will allow the FDA to more quickly identify, analyze, and notify the public of potential issues. In addition to recall notices, safety communications, and press releases, "We believe there also is a need to notify the public about emerging signals that the Agency is monitoring or analyzing, even when the information has not been fully analyzed, validated, or confirmed, and for which the Agency does not yet have specific recommendations," FDA states in draft guidance entitled Public Notification of Emerging Postmarket Medical Device Signals ('Emerging Signals').
Course Objective:
• Understand the proposed guidance on "Emerging Signals"
• Understand other areas of change such as eMDR and UDI that allow faster and more precise information
• Discuss the implications of these changes
• Understand how to change your Quality Management System from Reactive to Predictive
• Explore ways to prepare for FDA changes
Course Outline:
• Guidance on Emerging Signals
• Unique Device Identifier
• Electronic MDR reporting
• Case for Quality
• Moving from Reactive to Predictive Quality Management
What You Get:
• Training Materials
• Live Q&A Session with our Expert
• Participation Certificate
• Access to Signup Community (Optional)
• Reward Point
Who Will Benefit:
• Quality Systems Specialists
• Quality and Compliance Specialists
• Internal Auditors and Managers
• Quality/Compliance managers or directors for Medical Device companies
• General Managers wanting to strategize and prepare for future changes
Understanding the Brazilian Regulatory Environment for Medical Devices
Get Instant Access 60 Minutes View Program |
Special Considerations during Medical Device Design - Dos and Don'ts
Get Instant Access 60 Minutes View Program |
Effective Records Management & Document Control for Medical Devices
Get Instant Access 60 Minutes View Program |
The Use and Misuse Of FMEA In Medical Device Risk Management
Get Instant Access 75 Minutes View Program |
Designing Medical Devices for Safety, Reliability, and Maintainability
Get Instant Access 75 Minutes View Program |
Get Instant Access On-Demand Access
Preparing for the ICE Storm: What to Do During I 9 Audits and ICE Raids
Janette S. Levey
Human Resources
Get Instant Access On-Demand Access
OSHA Inspections and Investigations-How to Manage Them
Irwin Dobrushin
Environment Health and Safety | OSHA
Get Instant Access On-Demand Access
29 CFR 1904: OSHA's New Injury Recordkeeping E-Submission Rule
Occupational Safety and Health Administration
Get Instant Access On-Demand Access
Working with Excel Databases: Sort, Filter, Subtotal and More
Cathy Horwitz
Cross Industry | Skill Enhancement
Get Instant Access On-Demand Access
Writing Audit Reports
Jonnie T. Keith CIA, CFE, CGAP, CICA
Governance, Risk and Compliance
Get Instant Access On-Demand Access
BSA Reporting Requirements
Banking and Financial Services Industry
Get Instant Access On-Demand Access
Human Factors-Usability Based on ISO 62366
Medical Device | Diagnostic | Pharmaceutical | Biologics fields
Get Instant Access On-Demand Access
Chat GPT for Project Managers
Charles H. Paul
All FDA Regulated Industry